Abiopharma

🔍 Carges Mark T (Director)

Company: VEEVA SYSTEMS INC (VEEV)

Report Date: 2026-06-17

Detailed Transactions and Holdings:

• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-17 | Code: H | nature_of_ownership: By Mark Carges Revocable Trust dated 01/30/2019 | shares_owned_after: 12,953.00 | Footnotes: F1, F2
• Acquired 1,970 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,970.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4

Footnotes:

• F1: The number of shares beneficially owned reflects the transfer of 271 shares of Class A Common Stock from the Reporting Person to the Mark Carges Revocable Trust dtd 1/30/19 (the "Trust"). The Reporting Person is a trustee and beneficiary of the Trust, and may be deemed to share voting and dispositive power with regard to the reported shares held by the Trust.
• F2: Shares held by the Trust. The Reporting Person is a trustee and beneficiary of the Trust, and may be deemed to share voting and dispositive power with regard to the reported shares held by the Trust.
• F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.
• F4: The RSUs were granted under the Issuer's Amended & Restated 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year with 1/4 of the RSUs vesting on September 1, 2026, and 1/4 of the RSUs vesting on a quarterly basis thereafter, subject to continued service to the Issuer by the Reporting Person.